Projects per year
Search results
-
Active
UNTOLD: UNderstanding The experience of Ovarian cancer - Life after Diagnosis: A Mixed Methods Approach
Vogel, R. (PI), Blaes, A. H. (CoI), Girard, A. (CoI), Teoh, D. G. (CoI) & Brown, K. (Other Role)
CENTERS FOR DISEASE CONTROL & PREVENTION
9/30/24 → 9/29/26
Project: Research project
-
Increasing access to cancer trials in Minnesota (InACT-MN)
Erickson, B. K. (PI), Geller, M. A. (CoI), Greeno, E. W. (CoI), Kratzke, R. A. (CoI), Ondrey, F. G. (CoI), Teoh, D. G. (CoI) & Yee, D. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
9/18/23 → 8/31/28
Project: Research project
-
Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life
Vogel, R. (PI), Blaes, A. H. (CoI) & Teoh, D. G. (CoI)
NIH NATIONAL CANCER INSTITUTE (NCI)
2/3/23 → 1/31/27
Project: Research project
-
Increasing HPV vaccination coverage among adolescent and young adult (AYA) cancer survivors: A multilevel intervention
Teoh, D. G. (PI), Melton-Meaux, G. B. (CoI), Sadak, K. T. (CoI) & Vogel, R. (CoI)
8/15/21 → 8/14/25
Project: Research project
-
Phase 1 First-in-Human Study of Leukocyte Immunoglobulin-Like Receptor B2 (LILRB2) Inhibitor Monoclonal Antibody (mAb) JTX-8064, as Monotherapy and in Combination with a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, in Adult Subjectswith Advanced
Teoh, D. G. (PI)
5/1/21 → 4/30/26
Project: Research project
-
Finished
NRG-GY023: A RANDOMIZED PHASE II TRIAL OF TRIPLET THERAPY (A PD-L1 INHIBITOR DURVALUMAB(MEDI4736) IN COMBINATION WITH OLAPARIB AND CEDIRANIB) COMPARED TO OLAPARIB ANDCEDIRANIB OR DURVALUMAB (MEDI4736) AND CEDIRANIB OR STANDARD OF CARE CHEMOTHERAPYIN W
Teoh, D. G. (PI)
NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)
10/29/21 → 2/28/25
Project: Research project
-
Optimizing cervical cancer screening for HPV-vaccinated women: Evaluation of post-vaccination cervical cancer screening test
Teoh, D. G. (PI), Kulasingam, S. L. (CoI), Melton-Meaux, G. B. (CoI) & Vogel, R. (CoI)
U.S. DEPT OF HEALTH & HUMAN SERV AHRQ
6/1/19 → 5/31/21
Project: Research project
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Teoh, D. G. (PI)
NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)
3/15/19 → 2/28/25
Project: Research project
-
Phase II Study of Pembrolizumab in Combination with Carboplatin and Paclitaxel for Advanced or Recurrent Endometrial Adenocarcinoma
Teoh, D. G. (PI)
BIG TEN CANCER RESEARCH CONSORTIUM
12/1/17 → 11/30/22
Project: Research project
-
mRNA-2416-P101
Teoh, D. G. (PI) & Gupta, S. (Prior Principal Investigator)
1/1/17 → 1/30/23
Project: Research project
-
The Urinary Microbiome in Women with Cervical Cancer: Wh
Teoh, D. G. (PI) & Glasgow, M. A. (CoI)
SOCIETY OF GYNECOLOGIC ONCOLOGY
1/1/15 → 12/31/16
Project: Research project
-
MASTER NRG Oncology Studies
Geller, M. A. (PI) & Teoh, D. G. (CoI)
NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)
3/1/14 → 7/31/19
Project: Research project
-
Negative Pressure Wound Therapy in Obese Gynecologic
Teoh, D. G. (PI)
7/1/13 → 6/30/20
Project: Research project